PL2029121T3 - Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej - Google Patents

Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej

Info

Publication number
PL2029121T3
PL2029121T3 PL07725656T PL07725656T PL2029121T3 PL 2029121 T3 PL2029121 T3 PL 2029121T3 PL 07725656 T PL07725656 T PL 07725656T PL 07725656 T PL07725656 T PL 07725656T PL 2029121 T3 PL2029121 T3 PL 2029121T3
Authority
PL
Poland
Prior art keywords
active ingredient
therapeutic system
transdermal therapeutic
flux
water
Prior art date
Application number
PL07725656T
Other languages
English (en)
Inventor
Michael Horstmann
Mohammad Sameti
Tobias Jung
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38520773&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2029121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of PL2029121T3 publication Critical patent/PL2029121T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07725656T 2006-06-08 2007-05-30 Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej PL2029121T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006026578A DE102006026578B4 (de) 2006-06-08 2006-06-08 Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
EP07725656A EP2029121B1 (de) 2006-06-08 2007-05-30 Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
PCT/EP2007/004765 WO2007140909A1 (de) 2006-06-08 2007-05-30 Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss

Publications (1)

Publication Number Publication Date
PL2029121T3 true PL2029121T3 (pl) 2010-06-30

Family

ID=38520773

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07725656T PL2029121T3 (pl) 2006-06-08 2007-05-30 Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej

Country Status (13)

Country Link
US (2) US10292942B2 (pl)
EP (1) EP2029121B1 (pl)
JP (1) JP5757682B2 (pl)
CN (1) CN101466361B (pl)
AT (1) ATE459345T1 (pl)
BR (1) BRPI0712420A2 (pl)
CA (1) CA2652216C (pl)
DE (2) DE102006026578B4 (pl)
DK (1) DK2029121T3 (pl)
ES (1) ES2340732T3 (pl)
PL (1) PL2029121T3 (pl)
PT (1) PT2029121E (pl)
WO (1) WO2007140909A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
US8369942B2 (en) * 2008-03-20 2013-02-05 The Invention Science Fund I, Llc Subdermal material delivery device
US20090264806A1 (en) 2008-04-16 2009-10-22 Kei Tamura Transdermal drug administration device
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
MX2013001936A (es) 2010-08-23 2013-03-08 Takeda Gmbh Particulas humidificadas que comprenden una sustancia terapeuticamente activa.
DE102011090178A1 (de) * 2011-12-30 2013-07-04 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation
DK2810646T3 (en) 2013-06-04 2016-10-31 Lts Lohmann Therapie Systeme Ag A transdermal
JP6542364B2 (ja) 2014-10-21 2019-07-10 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 皮膚の外観を改善する方法
CN104758181A (zh) * 2015-04-09 2015-07-08 史祎 一种无溶剂贴敷剂制备工艺
WO2017070078A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US9872816B2 (en) 2015-10-22 2018-01-23 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
JP6974922B2 (ja) 2017-01-09 2021-12-01 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 可溶性フィルムを有するバリアパッチ及び皮膚の外観を改善する方法
US10751265B2 (en) * 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
EP3641952B1 (en) * 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
KR102524880B1 (ko) * 2017-12-21 2023-04-21 한양대학교 산학협력단 하이드로콜로이드 조성물 및 이를 포함하는 바이오 패치
CN111698984B (zh) 2018-03-19 2023-11-14 宝洁公司 制备具有可溶性膜的阻隔贴片的方法
US20220280443A1 (en) * 2021-03-08 2022-09-08 Nikita Patel Transdermal Delivery System

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3965482A (en) * 1974-11-12 1976-06-22 Rca Corporation Velocity correction circuit for video discs
US4460372A (en) 1981-02-17 1984-07-17 Alza Corporation Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
US4687481A (en) 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
ATE95430T1 (de) * 1984-12-22 1993-10-15 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster.
GB8629640D0 (en) 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
US5059189A (en) 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
IT1230566B (it) 1988-10-17 1991-10-28 Vectorpharma Int Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
DE4332093C2 (de) 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US6238700B1 (en) 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
WO1999017868A1 (de) * 1997-10-06 1999-04-15 Adalbert-Raps-Stiftung Verfahren zur herstellung eines pulverförmigen produktes aus einem flüssigen stoff oder stoffgemisch
DE19844079A1 (de) * 1998-05-22 1999-11-25 Novosis Pharma Ag Biphasische Transdermalsysteme
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung

Also Published As

Publication number Publication date
US10292942B2 (en) 2019-05-21
CA2652216A1 (en) 2007-12-13
US10596126B2 (en) 2020-03-24
DE102006026578A1 (de) 2007-12-13
ES2340732T3 (es) 2010-06-08
US20090258062A1 (en) 2009-10-15
DK2029121T3 (da) 2010-06-07
CN101466361A (zh) 2009-06-24
WO2007140909A1 (de) 2007-12-13
PT2029121E (pt) 2010-05-11
BRPI0712420A2 (pt) 2012-09-04
DE102006026578B4 (de) 2009-01-08
EP2029121B1 (de) 2010-03-03
ATE459345T1 (de) 2010-03-15
JP5757682B2 (ja) 2015-07-29
US20190231710A1 (en) 2019-08-01
CN101466361B (zh) 2012-01-04
EP2029121A1 (de) 2009-03-04
CA2652216C (en) 2016-02-16
JP2009539786A (ja) 2009-11-19
DE502007003020D1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
PL2029121T3 (pl) Transdermalny system terapeutyczny zawierający cząstki substancji czynnej, o zwiększonym przepływie substancji czynnej
WO2010125475A3 (en) Sustained release formulations comprising gnrh analogues
RS20080439A (en) Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer
WO2012040623A3 (en) Nanostructured gels capable of controlled release of encapsulated agents
MX362838B (es) Composiciones farmacéuticas de liberación prolongada para disuadir el abuso de opioides que comprenden un plastómero, un elastómero y un plastificante delicuescente.
WO2006124047A3 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
MX362357B (es) Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis.
TW200727919A (en) Guaifenesin sustained release formulation and tablets
PT2043600T (pt) Formulações farmacêuticas para a libertação prolongada de princípio(s) ativo(s), assim como suas aplicações, nomeadamente terapêuticas
WO2006099514A3 (en) Drug delivery compositions and related methods
WO2006094113A8 (en) Mask container
WO2010100650A3 (en) Therapeutic uses of mastic gum fractions
WO2008067164A3 (en) Solid pharmaceutical dosage formulations
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
WO2012048176A3 (en) Attachment and retention formulations for biologically active organic compounds
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
MX2010000965A (es) Productos de farmaco de interferon de liberacion controlada y tratamiento de la infeccion del virus de hepatitis c usando los mismos.
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
WO2008101173A3 (en) Biodegradable compositions and materials